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REVIOUS studies have shown that abnormalities occur in the cerebral circulation following experimental fluid-percussion brain injuryY These abnormalities include endothelial lesions in cerebral arteries, arteriolar dilation, and ]oss of arteriolar reactivity to hyperventilation. Additional data indicate that reactivity to other vasoactive substances such as acetylcholine is also modified after traumatic brain injury or acute arterial hypertension. ~2,17 These abnormalities of the cerebral arterioles are induced by posttraumatic initiation of arachidonic acid metabolism by cyclooxygenase with concomitant formation of oxygen radicals.*7 '27 It has been well documented that oxygen radicals influence these abnormalities, since treatment of animals with indomethacin (which blocks the cyclooxygenase enzyme) or treatment with the free radical scavengers superoxide dismutase and catalase inhibit formation of the arteriolar abnormalities and maintain normal cerebrovascular reactivity to hyperventilation. 17, 27 Recent studies also show that, following acute pressor-induced arterial hypertension similar to the arterial hypertension produced by experimental fluid-percussion brain injury, there is a continuing production of oxygen radicals and an abnormal cerebral arteriolar reactivity to acetylcholine, which is reversed to normal vasodilation by superoxide dismutase plus catalase) 6 Ellison, et al., ~2 have demonstrated that acetylcholine reactivity of cerebral arterioles is modified for several hours following experimental traumatic brain injury. This implies that there is a period of time after brain injury in which treatment with free radical scavengers may restore normal reactivity. To date, there have been few studies aimed at administration of free radical scavengers after injury; however, free radicals continue to be produced after injury, suggesting that therapy after trauma with free radical scavengers may be useful.
Most studies of free radical scavengers have utilized superoxide dismutase (an enzyme that scavenges the superoxide anion radical) and catalase (another enzyme that converts hydrogen peroxide to water and oxygen). It may be very difficult to use these enzymes therapeutically in humans, however, since each has a very limited half-life. Also, these large enzyme molecules do not appear readily to cross the blood-brain barrier. 6 Nacetylcysteine, the active ingredient in Mucomyst, has been utilized for a number of years as a mucolytic agent and more recently as the antidote for acetaminophen overdose, z9 Recently, Aruoma, et al., 2 have shown that r~acetylcysteine scavenges hydroxyl radicals and hypochlorous radicals. Studies in animals have shown that n-acetylcysteine inhibits free radical formation. 4' 22 Therefore, we have investigated whether n-acetylcysteine may be useful as a free radical scavenger following traumatic brain injury. Our evidence suggests that administration of n-acetylcysteine either preinjury or postinjury restores normal cerebrovascular reactivity to hyperventilation following concussive brain injury. The advantage of n-acetylcysteine as a free radical scavenger is that it is already an approved drug and is more readily available in the clinical setting.
Materials and Methods

Cat Studies
Animal Preparation and Experimental Injury. Fluid-percussion brain injury was administered to anesthetized cats as previously reported in detail. 27 The protocol was approved by The Medical College of Virginia's Institutional Animal Care and Use Committee. The studies were conducted on 17 cats divided into three groups: a control group (six cats); a group pretreated with n-acetylcysteine (five cats); and a group treated with n-acetylcysteine at 30 minutes after injury (six cats). The cats were anesthetized with pentobarbital (35 mg/kg given intravenously) and cannulas were inserted into the femoral arteries for monitoring blood pressure and withdrawing samples for blood gas measurement. A vein was cannulated for administration of additional anesthetic, which was given as indicated by spontaneous fluctuations in blood pressure or return of pain reflexes. Additional doses of pentobarbital generally did not exceed 6 mg/kg at each administration. The respirator rate and volume were adjusted to keep the end-expiratory PaCO2 at 28 to 33 mm Hg and blood gases in the normal range. Body temperature was maintained at 37'C with the use of a thermistor temperature controller and a heated circulating water pad.
Experimental traumatic brain injury was produced by fluid-percussion injury, which simulates concussive brain injury. The details of the fluid-percussion model have been previously reported. 27 In order to implant the injury device, a craniectomy was first made over one parietal cortex and a connector was attached and held in place with the use of dental acrylic? ' 27 A fluidfilled cylinder was then attached to the connector. The fluid-filled cylinder had a plunger on the end opposite the connector, which was struck by a pendulum dropped from a fixed height. Striking the plunger caused a fluid displacement wave to be sent down the cylinder through the connector and into the cranial vault. With this procedure, a very reproducible injury can be obtained. The pressure pulse caused damage throughout the cranial vault. The magnitude and duration of the pressure pulse were recorded by a pressure transducer, which was connected to a storage oscilloscope.
On the contralateral hemisphere, a second cranieetomy was made for the placement of the cranial window, as previously described. 16 ' 27 The circular outline of the craniectomy was made with a high-speed drill and the bone was removed with rongeurs. This craniectomy procedure was used to avoid excessive heat or vibration in the area of cortex to be examined microscopically. The cranial window was held in place and sealed with dental acrylate; this window had three openings, which were used for adding and withdrawing artificial cerebrospinal fluid (CSF). The third port of the window was connected to CSF-filled tubing, of which the open end was elevated to maintain a constant intracranial pressure of 5 mm Hg. The diameter response of the pial arterioles was measured through the window using a microscope and an image-shearing device, s,2o
Preinjury Treatment Studies. Animals pretreated with n-acetylcysteine were given additional n-acetylcysteine, 163 mg/kg intraperitoneally, 30 minutes before the concussive injury and again at 5 minutes before brain injury, thus making the total systemic preinjury dose 326 mg/kg. N-acetylcysteine was also dissolved in the artificial CSF (163 ug/ml) used to fill the space under the cranial window, and 1 ml of this CSF solution was flushed through the cranial window. Since the volume between the window and the surface of the brain was approximately 0.1 ml, there was 10-fotd flushing of the area under the cranial window. After the pretreatment with n-acetylcysteine at 30 minutes and immediately before the injury, the animals were hyperventilated in order to reduce the end-expiratory PaCO: to approximately 17 mm Hg. During the steadystate response to hyperventilation, arteriolar diameters were measured and compared to those during normal ventilation. Ventilation and blood gas levels were then returned to baseline and the injury was administered. Blood pressure and arteriolar diameter responses were measured periodically up to 1 hour after injury. At 1 hour after injury, the animal was hyperventilated similarly to before injury, and arteriolar reactivity was assessed.
Postinjury Treatment Studies. In animals treated after injury with n-acetylcysteine, a similar protocol was utilized as with pretreatment except that n-acetylcysteine was given only systemically (163 mg/kg intraperitoneally) at 30 minutes after injury. At no time was n-acetylcysteine administered into the CSF. As in the pretreatment group, reactivity was assessed 1 hour after injury, thus making the reactivity test time 30 minutes after systemic administration of n-acetylcysteine. * Values represent the mean + standard error of the mean. All parameters in all groups were similar except that the control arteriolar diameter in the group receiving n-acetylcysteine after injury was significantly (t" = P < 0.05) smaller than in the control group or in those receiving n-acetylcysteine before injury.
Rabbit Studies
Animal Preparation. We also examined the potential mechanism by which n-acetylcysteine protected cerebrovascular reactivity. For these experiments we utilized the acute cranial window technique in rabbits. Rabbits were chosen because of reduced cost and because we have previously performed numerous experiments in rabbits aimed at determining free radical responses. As previously reported, an acute cranial window was implanted for measurement of arteriolar diameter responses using an image-shearing deviceJ 6 As in the cat experiments, the rabbits were ventilated to maintain a constant end-expiratory PaCO2 of 28 to 33 mm Hg and stable blood gas levels.
Studies of N-Acetylcysteine Prevention of RadicalMediated Dilation.
In order to study the potential free radical scavenging mechanisms of n-acetylcysteine, we employed two vasoactive agents known to produce dilation via production of oxygen radicals. 7'~8'24 These agents include topically applied arachidonic acid (a substrate for cyclo-oxygenase-dependent production of free radicals) and bradykinin (an agent that produces dilation via stimulation of cyclo-oxygenase metabolism of arachidonic acid). Dilation induced by both of these agents can be prevented by indomethacin or the free radical scavengers superoxide dismutase plus catalase. 7''6''8 The specificity of indomethacin and superoxide dismutase plus catalase has been well established since these agents do not reduce pial arteriolar dilation produced by adenosine or acetylcholine. TM 18 In the current study we tested for the specificity of the n-acetylcysteine effect by determining its action on dilation induced by the topical application of 2-chloroadenosine. This stable adenosine analog is not readily metabolized and produces strong, long-lasting dilation of E
Graph showing the effect of n-acetylcysteine (NAC) on the pial arteriolar response to hyperventilation (HV) following fluid-percussion brain injury. Responses are the mean _+ standard error of the mean for the control (six cats), pretreated (five cats), and posttreated (six cats) groups. Note that following injury, the untreated animals showed no arteriolar constriction in response to hyperventilation whereas the animals receiving n-acetylcysteine either before or 30 minutes after injury showed significant constriction in response to hyperventilation (* = p < 0.05). It can also be seen that the group receiving NAC after injury (the group with a significantly smaller control diameter, see Table 1 ) showed more dilation than the other two groups in response to injury (p < 0.05). This greater dilation in the injury-induced group of small arterioles is consistent with previous studies of arteriolar responses following experimental fluid-percussion brain injury. 17, 27 cerebral arterioles by a mechanism that does not involve arachidonic acid metabolism or oxygen radicals. ~3
Pial arteriolar dilation in response to bradykinin (1 uM) and arachidonic acid (16 uM) was measured in two groups of rabbits. One group was not treated with n-acetylcysteine before receiving cortically applied bradykinin or arachidonic acid, while the second group received both systemic and topically applied n-acetylcysteine before application of bradykinin and arachidonic acid. The group of rabbits that was pretreated with n-acetylcysteine received one intraperitoneal dose of n-acetylcysteine (163 mg/kg) 30 minutes before assessing the diameter response; in addition, n-acetylcysteine (1 ml, 163 #g/ml) was administered along with arachidonic acid and bradykinin into the artificial CSF. Before applying the n-acetylcysteine with either arachidonic acid or bradykinin, the n-acetylcysteine was applied topically to determine whether it alone had any effect on arteriolar diameter. Control animals received only intraperitoneally injected saline or artificial CSF at the same times at which n-acetylcysteine was administered.
Diameter and Data Analysis. Two to four arterioles were studied in each animal. The arteriolar responses to a given manipulation in each animal were averaged, and this single number was used to compute the average for a group of animals. Data were analyzed using Student's t-test or by analysis of variance followed by a multiple range test. A p value of 0.05 or less was considered significant.
FIG. 2.
Graph showing that n-acetylcysteine (NAC) reduces oxygen radical-dependent cerebral arteriolar dilation induced by bradykinin (BK) and arachidonic acid (AA) in rabbits. * = Values significantly different from the control response at p < 0.05. Responses are the mean _+ standard error of the mean. n = number of rabbits. ments were performed in rabbits to assess the capacity of n-acetylcysteine to prevent cerebral arteriolar dilation by two agents known to produce dilation by production of free radicals. Figure 2 shows the response to 16 uM arachidonic acid and 1 uM bradykinin in the presence or absence of n-acetylcysteine. It may be seen that, in those animals not receiving n-acetylcysteine, both bradykinin and arachidonic acid induced dilation similar to that which has been previously reportedfl 6,~s However, in animals pretreated with n-acetylcysteine, arteriolar dilation in response to arachidonate and bradykinin was greatly reduced. In order to determine whether n-acetylcysteine was a nonspecific blocker of all vasodilator substances, we tested the effect of similarly administered n-acetylcysteine on dilation induced by 2-chloroadenosine. We found that the dilation induced by 33 t~M 2-chloroadenosine was not affected by treatment with n-acetylcysteine (data not shown).
Results
N-acetylcysteine given systemically and topically under the window had no effect on blood pressure or control arteriolar diameter (data not shown). Table 1 gives the control physiological variables and the maximum postinjury blood pressure response to traumatic injury in cats. Mean arterial blood pressure was similar in all three groups before brain injury. After brain injury, mean arterial blood pressure rose to an average of 201 to 222 mm Hg. The injury response, in terms of atmospheres of injury pressure, was similar in all animals. The baseline vessel diameter in the control group was similar to that in the group receiving nacetylcysteine before injury; however, through no intentional means, the control arteriolar diameter of those arterioles examined in animals treated after injury with n-acetylcysteine was significantly smaller (p < 0.05). Figure 1 shows that all groups responded similarly to hyperventilation administered before the traumatic concussive brain injury. After injury, the extent of vascular dilation varied somewhat between groups, animals posttreated with n-acetylcysteine exhibited significantly (p < 0.05) more dilation than the other two groups of animals. Animals that were not pharmacologically protected did not react normally to hyperventilation at 1 hour after injury. However, both groups receiving n-acetylcysteine, whether preinjury or postinjury, displayed cerebral arteriolar constriction in response to arterial hypocapnia produced by hyperventilation (Fig. 1) . While the average diameter response to hyperventilation can be seen in Fig. 1 , it should be noted that every animal in the two n-acetylcysteinetreated groups responded to postinjury hyperventilation. This response differed from the control group, in which postinjury hyperventilation did not produce vasoconstriction in any animal examined.
In order to provide evidence that n-acetylcysteine is an oxygen radical scavenger in vivo, additional experi-
Discussion
In the currently utilized fluid-percussion brain injury technique, brain damage is caused by a 20-msee fluid displacement into the cranial vault. Damage occurs throughout the cranial vault and results in axonal damage as well as vascular injury. Associated with fluidpercussion brain injury in cats is a transient period of hypertension that occurs within 30 seconds of brain injury. This hypertension is known to occur as a result of a massive sympathetic discharge and adrenal catecholamine releaser 5 Cerebral arterioles remain dilated after brain injury and the degree of dilation is known to be greater in small arterioles. 17.27 From Fig. 1 it can be seen that the control arteriolar diameter in the group of cats treated after injury with n-acetylcysteine was smaller than in the other two groups. Correspondingly, in agreement with previous studies, these vessels dilated more in response to injury.
We have previously shown that, following experimental fluid-percussion injury in cats, topical application of superoxide dismutase plus catalase prevented endothelial lesions and arteriolar dilation and reduced the arteriolar responsiveness to arterial hypocapnia that normally occurs after injury. 27 Oxygen radicals are formed not only after traumatic brain injury but also after brain injury induced by other experimental methods including cold lesions 6 and reflow following ischemia? 'z~ The mechanism by which free radicals are formed in the brain immediately after experimental fluid-percussion injury likely involves cyclo-oxygenase metabolism of arachidonic acid since the presence of indomethacin blocks posttraumatic brain oxygen radical formation and the occurrence of arteriolar abnormalities. 27 In this regard, Kukreja, et aL, 19 have provided convincing evidence that the mechanism by which arachidonic acid metabolism produces oxygen radicals involves a side-chain reaction of a peroxidase enzyme-centered radical with the reduced form of nicotinamide-adenine dinucleotide or a reduced form of nicotinamide-adenine dinucleotide phosphate to produce a nicotinamide-adenine dinucleotide radical or oxidized form of dinucleotide phosphate radical, which in turn can form oxygen radicals in the presence of 02. We have recently shown that, in addition to the direct action of cyclo-oxygenase on arachidonic acid, with subsequent formation of prostaglandins and oxygen radicals, the cytochrome P-450/epoxygenase metabolites of arachidonic acid are also metabolized by cyclooxygenase with concomitant formation of oxygen radicals. ''m Since we have also shown that the brain is capable of making P-450/epoxygenase metabolites that are substrates for cyclo-oxygenase, this implies that both direct metabolism of arachidonic acid and metabolism of P-450 metabolites of arachidonic acid by cyclooxygenase are capable of forming oxygen radicals.
Our results imply that the formation of oxygen radicals continues after the initial traumatic insult since administration of n-acetylcysteine at 30 minutes after injury effectively allows normal cerebral arteriolar reactivity. This is in agreement with the recent work of Ellison,et al., '2 who showed that cerebrovascular reactivity to acetylcholine is attenuated for several hours after fluid-percussion brain injury in cats. Additionally, Wei, el al., 26 have shown that, following acute hypertension similar to hypertension produced by brain injury, abnormal cerebral arteriolar reactivity to topically applied acetylcholine is due to oxygen radical formation, since treatment with superoxide dismutase restores normal reactivity. Further evidence that oxygen radicalmediated injury continues after the damaging challenge is derived from our recent studies, which show that brain edema caused by acute hypertension can be eliminated even when superoxide dismutase or polyethylene glycol-conjugated superoxide dismutase is given after the acute hypertensive challenge. 28 This continuing production of radicals after injury suggests that administration of free radical scavengers to humans in the early hours after injury may be of benefit. The concept that human cerebrovascular reactivity, like that in experimentally traumatized animals, is altered after traumatic brain injury is supported by the findings of Marmarou and Wachi, 23 who have shown in 40 patients that cerebrovascular reactivity to increases or decreases in arterial CO2 tension is reduced in the initial 24-hour period after traumatic brain injury.
Our studies with n-acetylcysteine and bradykininand arachidonic acid-induced dilation provide evidence that n-acetylcysteine is an oxygen radical scavenger. Previous studies by several laboratories have shown that dilation of cerebral arterioles induced by arachidonate and bradykinin is due to formation of dilator oxygen radicals? 8'24 Dilation induced by both of these agents can be blocked by superoxide dismutase plus catalase. Additionally, the formation of oxygen radicals, as indirectly measured by the reduction of nitroblue tetrazolium, is caused by bradykinin and arachidonic acid and is prevented by indomethacin or superoxide dis-E. F Ellis, L. Y. Dodson, and R. J. Police mutase plus catalase. We have also provided evidence that free radical-mediated cerebral arteriolar dilation can be induced by activation of the brain's endogenous kallikrein-kinin system. 7 Yet other studies have provided evidence that the endogenous mechanism that initiates cyclo-oxygenase metabolism and free radical formation following experimental fluid-percussion brain injury is activation of bradykinin receptors. 8 This conclusion is based on our previous findings that a specific bradykinin receptor antagonist reduces experimental posttraumatic arteriolar dilation and helps maintain arteriolar responsiveness to hyperventilation, much as n-acetylcysteine does in the current study.
The mechanism by which n-acetylcysteine scavenges oxygen radicals in injured brain may include two possibilities. First, it may be a direct scavenging agent. Second, by promoting the formation of glutathione it may enhance the activity of glutathione peroxidase, which inactivates hydrogen peroxide. It is well known that hydrogen peroxide can form hydroxyl radicals by the Fenton reaction, which is also called the iron catalyzed Haber-Weiss reactionJ 4 In our study, wherein nacetylcysteine blocks or reduces arachidonate-and bradykinin-induced rabbit arteriolar dilation, it might be argued that n-acetylcysteine is nonspecific and prevents all dilator responses. Evidence against this is that nacetylcysteine did not affect the arteriolar dilation induced by 2-chloradenosine, which causes dilation by a nonradical mechanism. ~5
Compared to studies with radical scavengers such as superoxide dismutase and catalase, relatively few studies have investigated the scavenging capacity of nacetylcysteine. However, in a series of studies by Bernard, et at., 4 and Lucht, et al., 22 it was shown that administration of n-acetylcysteine attenuated the endotoxin-induced rise in pulmonary artery pressure and lymph flow and neutrophil aggregation. They also reported that n-acetylcysteine attenuated alterations in lung mechanics and provided evidence that it was a potent free radical scavenger in both biological and nonbiological free radical-generating systems. Other studies have shown that n-acetylcysteine may be an effective scavenger of oxygen radicals formed during cancer chemotherapy. 29 The above studies suggest a free radical scavenging capacity of n-acetylcysteine in vivo and are supported by the recent work of Aruoma, et al., 2 who showed by chemical methods that n-acetylcysteine scavenges hydroxyl radicals and is also a powerful scavenger of hypochlorous acid.
In summary, our data imply that n-acetylcysteine (Mucomyst), a relatively inexpensive and commonly available drug, may be useful for the treatment of oxygen free radical-mediated traumatic brain injury. However, additional studies are needed to evaluate whether the n-acetylcysteine-induced improvement in vessel reactivity to CO2 (observed in the present study) also confers improvement to other mechanisms that contribute to injury following brain trauma. Finally, outcome studies will be needed before clinical recommendalions can be made.
